Oct 19Function Therapeutics receives SBIR award to study potential treatment for liver disease (MASH)Function Therapeutics has been awarded a Phase 1 Small Business Innovation Research (SBIR) grant from the National Institute of Diabetes...
Oct 19Parmodulin shows beneficial effects in obese miceIn the Journal of Thrombosis and Haemostasis, the lab of Dr. James Luyendyk (Michigan State University) and colleagues reported the...
Jun 4Function Therapeutics receives SBIR award to study acute kidney injury (AKI)Function Therapeutics has been awarded a Phase 1 Small Business Innovation Research (SBIR) grant from the National Institute of Diabetes...